rx 821002 has been researched along with phenelzine in 1 studies
| Studies (rx 821002) | Trials (rx 821002) | Recent Studies (post-2010) (rx 821002) | Studies (phenelzine) | Trials (phenelzine) | Recent Studies (post-2010) (phenelzine) |
|---|---|---|---|---|---|
| 317 | 0 | 45 | 1,407 | 203 | 87 |
| Protein | Taxonomy | rx 821002 (IC50) | phenelzine (IC50) |
|---|---|---|---|
| Cytochrome P450 3A4 | Homo sapiens (human) | 2 | |
| Cytochrome P450 2D6 | Homo sapiens (human) | 1 | |
| Cytochrome P450 2C9 | Homo sapiens (human) | 4 | |
| Amine oxidase [flavin-containing] A | Homo sapiens (human) | 0.192 | |
| Amine oxidase [flavin-containing] B | Homo sapiens (human) | 0.143 | |
| Cytochrome P450 2C19 | Homo sapiens (human) | 0.8 | |
| Membrane primary amine oxidase | Homo sapiens (human) | 0.02 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| García-Fuster, MJ; García-Sevilla, JA | 1 |
1 other study(ies) available for rx 821002 and phenelzine
| Article | Year |
|---|---|
Effects of anti-depressant treatments on FADD and p-FADD protein in rat brain cortex: enhanced anti-apoptotic p-FADD/FADD ratio after chronic desipramine and fluoxetine administration.
Topics: Adrenergic alpha-Antagonists; Animals; Antidepressive Agents; Apoptosis; Autoreceptors; Blotting, Western; Brain; CASP8 and FADD-Like Apoptosis Regulating Protein; Cerebral Cortex; Clorgyline; Desipramine; Electroshock; Excitatory Amino Acid Antagonists; Fas-Associated Death Domain Protein; Fluoxetine; Idazoxan; Indans; Ketamine; Male; Mianserin; Mirtazapine; Monoamine Oxidase Inhibitors; Norepinephrine Plasma Membrane Transport Proteins; Phenelzine; Phosphoproteins; Phosphorylation; Rats; RNA-Binding Proteins; Thiazoles | 2016 |